Six CAR-T-cell therapies have been approved by the European Commission and the US FDA, and other T-cell therapies are being ...

Larotrectinib for Newly Diagnosed Infantile Fibrosarcoma and Other Pediatric NTRK Fusion–Positive Solid Tumors (Children's Oncology Group ADVL1823) Sixteen patients were treated, with a median of four ...

the 5th European CAR T-cell Meeting, Rotterdam, the Netherlands, February 9-11, 2023; the European Bone Marrow Transplant association conference, Paris, France, April 23-26, 2023; and the ISA ...

The study provides an in-depth analysis of T cell development, beginning with their migration from bone marrow to the thymus, where they undergo critical selection and maturation processes. It ...

The study characterizes the lung cancer tumor microenvironment, linking cellular compositions to immunotherapy resistance and ...